Generation Bio, a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit, today announced the appointment of Richard Thompson, BM BCh, DM, a world-renowned specialist in pediatric liver disease, to its Scientific Advisory Board.
October 4, 2018
· 2 min read